Tony W. Ho
Overview
Tony W. Ho received an average of $5M in total compensation, including $387K in salary, at CRISPR Therapeutics AG from 2017 to 2021.
Source: SEC filings on April 25, 2022, April 28, 2021, April 24, 2020, and April 30, 2019.
Related executives
We found eight more executives who work or worked at CRISPR Therapeutics AG.
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
James Kasinger
CRISPR Therapeutics AG
General Counsel
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Rodger Novak
CRISPR Therapeutics AG
President
Marc Becker
CRISPR Therapeutics AG
Chief Financial Officer
Kala Subramanian
CRISPR Therapeutics AG
Senior Vice President, Strategic Development and Operations
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019